{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T05:46:31Z","timestamp":1750916791227},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s10557-015-6618-1","type":"journal-article","created":{"date-parts":[[2015,10,20]],"date-time":"2015-10-20T13:35:33Z","timestamp":1445348133000},"page":"451-459","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Effect of Metformin on Renal Function After Primary Percutaneous Coronary Intervention in Patients Without Diabetes Presenting with ST-elevation Myocardial Infarction: Data from the GIPS-III Trial"],"prefix":"10.1007","volume":"29","author":[{"given":"Rene A.","family":"Posma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris P. H.","family":"Lexis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"Lipsic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maarten W. N.","family":"Nijsten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Damman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daan J.","family":"Touw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk Jan","family":"van Veldhuisen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pim","family":"van der Harst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iwan C. C.","family":"van der Horst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,10,20]]},"reference":[{"key":"6618_CR1","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.jacc.2007.12.035","volume":"51","author":"PA McCullough","year":"2008","unstructured":"McCullough PA. Contrast-induced acute kidney injury. J Am Coll Cardiol. 2008;51:1419\u201328.","journal-title":"J Am Coll Cardiol"},{"key":"6618_CR2","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/eci.12061","volume":"43","author":"S Tehrani","year":"2013","unstructured":"Tehrani S, Laing C, Yellon DM, Hausenloy DJ. Contrast-induced acute kidney injury following PCI. Eur J Clin Invest. 2013;43:483\u201390.","journal-title":"Eur J Clin Invest"},{"key":"6618_CR3","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.carrev.2013.07.009","volume":"14","author":"K Kume","year":"2013","unstructured":"Kume K, Yasuoka Y, Adachi H, et al. Impact of contrast-induced acute kidney injury on outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Cardiovasc Revasc Med. 2013;14:253\u20137.","journal-title":"Cardiovasc Revasc Med"},{"key":"6618_CR4","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1093\/eurheartj\/ehu063","volume":"35","author":"A Narula","year":"2014","unstructured":"Narula A, Mehran R, Weisz G, et al. Contrast-induced acute kidney injury after primary percutaneous coronary intervention: results from the HORIZONS-AMI substudy. Eur Heart J. 2014;35:1533\u201340.","journal-title":"Eur Heart J"},{"key":"6618_CR5","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.ahj.2010.08.007","volume":"160","author":"AP Amin","year":"2010","unstructured":"Amin AP, Spertus JA, Reid KJ, et al. The prognostic importance of worsening renal function during an acute myocardial infarction on long-term mortality. Am Heart J. 2010;160:1065\u201371.","journal-title":"Am Heart J"},{"key":"6618_CR6","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1136\/hrt.2010.218677","volume":"97","author":"J Wi","year":"2011","unstructured":"Wi J, Ko Y-G, Kim J-S, et al. Impact of contrast-induced acute kidney injury with transient or persistent renal dysfunction on long-term outcomes of patients with acute myocardial infarction undergoing percutaneous coronary intervention. Heart. 2011;97:1753\u20137.","journal-title":"Heart"},{"key":"6618_CR7","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0195-668X(02)00526-2","volume":"24","author":"HL Hillege","year":"2003","unstructured":"Hillege HL, van Gilst WH, van Veldhuisen DJ, et al. Accelerated decline and prognostic impact of renal function after myocardial infarction and the benefits of ACE inhibition: the CATS randomized trial. Eur Heart J. 2003;24:412\u201320.","journal-title":"Eur Heart J"},{"key":"6618_CR8","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijcard.2011.05.079","volume":"163","author":"D Tziakas","year":"2013","unstructured":"Tziakas D, Chalikias G, Stakos D, et al. Development of an easily applicable risk score model for contrast-induced nephropathy prediction after percutaneous coronary intervention: a novel approach tailored to current practice. Int J Cardiol. 2013;163:46\u201355.","journal-title":"Int J Cardiol"},{"key":"6618_CR9","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.amjcard.2014.02.004","volume":"113","author":"D Tziakas","year":"2014","unstructured":"Tziakas D, Chalikias G, Stakos D, et al. Validation of a new risk score to predict contrast-induced nephropathy after percutaneous coronary intervention. Am J Cardiol. 2014;113:1487\u201393.","journal-title":"Am J Cardiol"},{"key":"6618_CR10","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1001\/jama.2014.15298","volume":"312","author":"SE Inzucchi","year":"2014","unstructured":"Inzucchi SE, Lipska KJ, Mayo H, Bailey CJ, McGuire DK. Metformin in patients with type 2 diabetes and kidney disease: a systematic review. JAMA. 2014;312:2668\u201375.","journal-title":"JAMA"},{"key":"6618_CR11","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/pds.3432","volume":"22","author":"AM Hung","year":"2013","unstructured":"Hung AM, Roumie CL, Greevy RA, et al. Kidney function decline in metformin versus sulfonylurea initiators: assessment of time-dependent contribution of weight, blood pressure, and glycemic control. Pharmacoepidemiol Drug Saf. 2013;22:623\u201331.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"6618_CR12","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/ki.2011.444","volume":"81","author":"AM Hung","year":"2012","unstructured":"Hung AM, Roumie CL, Greevy RA, et al. Comparative effectiveness of incident oral antidiabetic drugs on kidney function. Kidney Int. 2012;81:698\u2013706.","journal-title":"Kidney Int"},{"key":"6618_CR13","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.2215\/CJN.09291010","volume":"6","author":"JM Lachin","year":"2011","unstructured":"Lachin JM, Viberti G, Zinman B, et al. Renal function in type 2 diabetes with rosiglitazone, metformin, and glyburide monotherapy. Clin J Am Soc Nephrol. 2011;6:1032\u201340.","journal-title":"Clin J Am Soc Nephrol"},{"key":"6618_CR14","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1093\/ndt\/gfs375","volume":"27","author":"D Fliser","year":"2012","unstructured":"Fliser D, Laville M, Covic A, et al. A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) clinical practice guidelines on acute kidney injury: part 1: definitions, conservative management and contrast-induced nephropathy. Nephrol Dial Transplant. 2012;27:4263\u201372.","journal-title":"Nephrol Dial Transplant"},{"key":"6618_CR15","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1007\/s00330-011-2225-0","volume":"21","author":"F Stacul","year":"2011","unstructured":"Stacul F, van der Molen AJ, Reimer P, et al. Contrast induced nephropathy: updated ESUR contrast media safety committee guidelines. Eur Radiol. 2011;21:2527\u201341.","journal-title":"Eur Radiol"},{"key":"6618_CR16","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.carj.2012.11.002","volume":"65","author":"RJ Owen","year":"2014","unstructured":"Owen RJ, Hiremath S, Myers A, Fraser-Hill M, Barrett BJ. Canadian Association of Radiologists consensus guidelines for the prevention of contrast-induced nephropathy: update 2012. Can Assoc Radiol J. 2014;65:96\u2013105.","journal-title":"Can Assoc Radiol J"},{"key":"6618_CR17","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1001\/jama.2014.3315","volume":"311","author":"CP Lexis","year":"2014","unstructured":"Lexis CP, van der Horst IC, Lipsic E, et al. Effect of metformin on left ventricular function after acute myocardial infarction in patients without diabetes: the GIPS-III randomized clinical trial. JAMA. 2014;311:1526\u201335.","journal-title":"JAMA"},{"key":"6618_CR18","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10557-012-6413-1","volume":"26","author":"CP Lexis","year":"2012","unstructured":"Lexis CP, van der Horst IC, Lipsic E, et al. Metformin in non-diabetic patients presenting with ST elevation myocardial infarction: rationale and design of the glycometabolic intervention as adjunct to primary percutaneous intervention in ST elevation myocardial infarction (GIPS)-III trial. Cardiovasc Drugs Ther. 2012;26:417\u201326.","journal-title":"Cardiovasc Drugs Ther"},{"key":"6618_CR19","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1093\/eurheartj\/ehs215","volume":"33","author":"PG Steg","year":"2012","unstructured":"Steg PG, James SK, Atar D, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012;33:2569\u2013619.","journal-title":"Eur Heart J"},{"key":"6618_CR20","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604\u201312.","journal-title":"Ann Intern Med"},{"key":"6618_CR21","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1053\/j.ajkd.2013.12.006","volume":"63","author":"AS Levey","year":"2014","unstructured":"Levey AS, Inker LA, Coresh J. GFR estimation: from physiology to public health. Am J Kidney Dis. 2014;63:820\u201334.","journal-title":"Am J Kidney Dis"},{"key":"6618_CR22","first-page":"1393","volume":"44","author":"R Mehran","year":"2004","unstructured":"Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004;44:1393\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"6618_CR23","doi-asserted-by":"crossref","first-page":"247","DOI":"10.7326\/0003-4819-145-4-200608150-00004","volume":"145","author":"AS Levey","year":"2006","unstructured":"Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145:247\u201354.","journal-title":"Ann Intern Med"},{"key":"6618_CR24","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.jacc.2014.01.087","volume":"64","author":"K Damman","year":"2014","unstructured":"Damman K, Perez AC, Anand IS, et al. Worsening renal function and outcome in heart failure patients with preserved ejection fraction and the impact of angiotensin receptor blocker treatment. J Am Coll Cardiol. 2014;64:1106\u201313.","journal-title":"J Am Coll Cardiol"},{"key":"6618_CR25","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrneph.2013.250","volume":"10","author":"B Braam","year":"2013","unstructured":"Braam B, Joles JA, Danishwar AH, Gaillard CA. Cardiorenal syndrome\u2014current understanding and future perspectives. Nat Rev Nephrol. 2013;10:48\u201355.","journal-title":"Nat Rev Nephrol"},{"key":"6618_CR26","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1161\/CIRCULATIONAHA.111.028282","volume":"125","author":"P Rossignol","year":"2012","unstructured":"Rossignol P, Cleland JG, Bhandari S, et al. Determinants and consequences of renal function variations with aldosterone blocker therapy in heart failure patients after myocardial infarction: insights from the eplerenone post-acute myocardial infarction heart failure efficacy and survival study. Circulation. 2012;125:271\u20139.","journal-title":"Circulation"},{"key":"6618_CR27","doi-asserted-by":"crossref","first-page":"F1346","DOI":"10.1152\/ajprenal.00420.2010","volume":"301","author":"PW Seo-Mayer","year":"2011","unstructured":"Seo-Mayer PW, Thulin G, Zhang L, et al. Preactivation of AMPK by metformin may ameliorate the epithelial cell damage caused by renal ischemia. AJP Ren Physiol. 2011;301:F1346\u201357.","journal-title":"AJP Ren Physiol"},{"key":"6618_CR28","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/ki.2010.11","volume":"77","author":"AI Morales","year":"2010","unstructured":"Morales AI, Detaille D, Prieto M, et al. Metformin prevents experimental gentamicin-induced nephropathy by a mitochondria-dependent pathway. Kidney Int. 2010;77:861\u20139.","journal-title":"Kidney Int"},{"key":"6618_CR29","doi-asserted-by":"crossref","first-page":"981","DOI":"10.2337\/db10-0655","volume":"60","author":"Y Takiyama","year":"2011","unstructured":"Takiyama Y, Harumi T, Watanabe J, et al. Tubular injury in a rat model of type 2 diabetes is prevented by metformin: a possible role of HIF-1\u03b1 expression and oxygen metabolism. Diabetes. 2011;60:981\u201392.","journal-title":"Diabetes"},{"key":"6618_CR30","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1148\/radiol.12121823","volume":"267","author":"RJ McDonald","year":"2013","unstructured":"McDonald RJ, McDonald JS, Bida JP, et al. Intravenous contrast material-induced nephropathy: causal or coincident phenomenon? Radiology. 2013;267:106\u201318.","journal-title":"Radiology"},{"key":"6618_CR31","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1177\/1060028013505428","volume":"47","author":"WR Lu","year":"2013","unstructured":"Lu WR, Defilippi J, Braun A. Unleash metformin: reconsideration of the contraindication in patients with renal impairment. Ann Pharmacother. 2013;47:1488\u201397.","journal-title":"Ann Pharmacother"},{"key":"6618_CR32","first-page":"99","volume":"96","author":"R Khurana","year":"2010","unstructured":"Khurana R, Malik IS. Metformin: safety in cardiac patients. Heart. 2010;96:99\u2013102.","journal-title":"Heart"},{"key":"6618_CR33","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/eurheartj\/eht386","volume":"35","author":"K Damman","year":"2014","unstructured":"Damman K, Valente MAE, Voors AA, O\u2019Connor CM, van Veldhuisen DJ, Hillege HL. Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis. Eur Heart J. 2014;35:455\u201369.","journal-title":"Eur Heart J"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-015-6618-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10557-015-6618-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-015-6618-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T19:06:13Z","timestamp":1553627173000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10557-015-6618-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["6618"],"URL":"https:\/\/doi.org\/10.1007\/s10557-015-6618-1","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10]]}}}